DAVITA HEALTHCARE PARTNERS's gross profit margin for the fourth quarter of its fiscal year 2014 has decreased when compared to the same period a year ago. Even though sales increased, the net income has decreased. DAVITA HEALTHCARE PARTNERS has strong liquidity. Currently, the Quick Ratio is 1.58 which shows the ability to cover short-term cash needs. The company's liquidity has increased from the same period last year.
During the same period, stockholders' equity ("net worth") has increased by 16.65% from the same quarter last year. The key liquidity measurements indicate that the company is unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q4 FY14||Q4 FY13|
|Net Sales ($mil)||3328.02||3063.21|
|Net Income ($mil)||208.02||212.28|
|Balance Sheet||Q4 FY14||Q4 FY13|
|Cash & Equiv. ($mil)||1302.64||953.05|
|Total Assets ($mil)||17942.72||17098.88|
|Total Debt ($mil)||8503.43||8415.93|
|Profitability||Q4 FY14||Q4 FY13|
|Gross Profit Margin||28.89||30.54|
|Return on Assets||4.03||3.7|
|Return on Equity||13.98||13.99|
|Debt||Q4 FY14||Q4 FY13|
|Share Data||Q4 FY14||Q4 FY13|
|Shares outstanding (mil)||215.64||213.16|
|Div / share||0.0||0.0|
|Book value / share||23.98||20.79|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||1283366.0||1219719.0|
BUY. This stock's P/E ratio indicates a significant discount compared to an average of 79.44 for the Health Care Providers & Services industry and a premium compared to the S&P 500 average of 20.44. To use another comparison, its price-to-book ratio of 3.40 indicates a premium versus the S&P 500 average of 2.82 and a discount versus the industry average of 3.94. The current price-to-sales ratio is below the S&P 500 average, but above the industry average. Upon assessment of these and other key valuation criteria, DAVITA HEALTHCARE PARTNERS proves to trade at a discount to investment alternatives within the industry.
|DVA 24.41||Peers 79.44||DVA 12.05||Peers 13.86|
Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.
DVA is trading at a significant discount to its peers.
Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
DVA is trading at a discount to its peers.
|DVA 20.00||Peers 19.90||DVA 2.06||Peers 1.79|
Average. An average price-to-projected earnings ratio can signify an industry neutral stock price and average future growth expectations.
DVA is trading at a valuation on par with its peers.
Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
DVA trades at a premium to its peers.
|DVA 3.40||Peers 3.94||DVA 15.37||Peers -13.30|
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
DVA is trading at a discount to its peers.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
DVA is expected to have an earnings growth rate that significantly exceeds its peers.
|DVA 1.37||Peers 0.89||DVA 8.76||Peers 13.97|
Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
DVA is trading at a significant premium to its industry.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
DVA significantly trails its peers on the basis of sales growth
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV